Briviact OverviewBrivaracetam (trade name Briviact), a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties. It is marketed by the pharmaceutical company UCB. In India it is co-promoted and distributed by Dr. Reddy's Laboratories. Contents 1 Medical uses 2 Adverse effects 3 Interactions 4 Pharmacology 4.1 Mechanism of action 4.2 Pharmacokinetics 5 Chemical and physical properties 6 History 7 References 8 External ...
Read more Briviact Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Brivaracetam
Recent Briviact Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 50mg/ml
- Solution: 10mg/ml, 50mg/5ml (10mg/ml)
- Tablet: 100mg, 10mg, 25mg, 50mg, 75mg
NDC Database Records for Briviact: (7 results)Sorted by National Drug Code
- 50474-370 Briviact 10 mg Oral Tablet, Film Coated by Ucb, Inc.
- 50474-470 Briviact 25 mg Oral Tablet, Film Coated by Ucb, Inc.
- 50474-570 Briviact 50 mg Oral Tablet, Film Coated by Ucb, Inc.
- 50474-670 Briviact 75 mg Oral Tablet, Film Coated by Ucb, Inc.
- 50474-770 Briviact 100 mg Oral Tablet, Film Coated by Ucb, Inc.
- 50474-870 Briviact 10 mg/ml Oral Solution by Ucb, Inc.
- 50474-970 Briviact 50 mg/5ml Intravenous Injection, Suspension by Ucb, Inc.